Trademark Overview
On Thursday, March 14, 2024, a trademark application was filed for ATLYPHE with the United States Patent and Trademark Office. The USPTO has given the ATLYPHE trademark a serial number of 79397822. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, January 21, 2025. This trademark is owned by ATLyphe AG. The ATLYPHE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of blood disorders, cardiovascular disorders, metabolic and endocrine disorders, immune system related diseases and disorders, oncological disorders, neurological disorders, infectious diseases, pain, inflammation; medical preparations for the treatment of blood disorders, cardiovascular disorders, metabolic and endocrine disorders, immune system related diseases and disorders, oncological disorders, neurological disorders, infectious diseases, pain, inflammation ; veterinary preparations for blood disorders; sanitary preparations for medical purposes; dietetic foods adapted for medical use; dietetic foods adapted for veterinary use; dietetic substances, namely, dietetic foods adapted for veterinary use; food for babies; dietary supplements for human beings and animals; plasters for medical purposes; materials for dressings, namely, gauze for dressings; materials for dental fillings and for making dental impressions; disinfectants; preparat...
Scientific services, namely, scientific research, analysis, testing, in the field of stems cells, immunotherapy, gene therapy; technological services, namely, medical research; scientific research; technological research in the field of medical diagnosis and healthcare; scientific and technological services, namely, research and design in the field of medical technology, devices and equipment; industrial analysis, namely, analysis and evaluation of medical and genetic data; industrial research in the field of immunotherapy, gene therapy and stems cells; industrial design services; quality control for others; quality authentication services, namely, authenticating organic and inorganic matters; design and development of computer hardware and software
